Study Name: Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
38 locations found
- 1237.6.01106 Boehringer Ingelheim Investigational Site
Location: Greer, California
- 1237.6.01120 Boehringer Ingelheim Investigational Site
Location: Fort Collins, Colorado
- 1237.6.01131 Boehringer Ingelheim Investigational Site
Location: Danbury, Connecticut
- 1237.6.01117 Boehringer Ingelheim Investigational Site
Location: Waterbury, Connecticut
- 1237.6.01118 Boehringer Ingelheim Investigational Site
Location: Deland, Florida
- 1237.6.01126 Boehringer Ingelheim Investigational Site
Location: Tampa, Florida
- 1237.6.01109 Boehringer Ingelheim Investigational Site
Location: Winter Park, Florida
- 1237.6.01134 Boehringer Ingelheim Investigational Site
Location: Atlanta, Georgia
- 1237.6.01107 Boehringer Ingelheim Investigational Site
Location: Couer d'Alene, Idaho
- 1237.6.01110 Boehringer Ingelheim Investigational Site
Location: Lafayette, Louisiana
- 1237.6.01128 Boehringer Ingelheim Investigational Site
Location: Baltimore, Maryland
- 1237.6.01130 Boehringer Ingelheim Investigational Site
Location: North Dartmouth, Massachusetts
- 1237.6.01104 Boehringer Ingelheim Investigational Site
Location: Minneapolis, Minnesota
- 1237.6.01116 Boehringer Ingelheim Investigational Site
Location: Plymouth, Minnesota
- 1237.6.01121 Boehringer Ingelheim Investigational Site
Location: St. Louis, Missouri
- 1237.6.01123 Boehringer Ingelheim Investigational Site
Location: St. Louis, Missouri
- 1237.6.01129 Boehringer Ingelheim Investigational Site
Location: Henderson, Nevada
- 1237.6.01136 Boehringer Ingelheim Investigational Site
Location: Marlton, New Jersey
- 1237.6.01108 Boehringer Ingelheim Investigational Site
Location: Albuquerque, New Mexico
- 1237.6.01127 Boehringer Ingelheim Investigational Site
Location: Bayside, New York
- 1237.6.01139 Boehringer Ingelheim Investigational Site
Location: Great Neck, New York
- 1237.6.01135 Boehringer Ingelheim Investigational Site
Location: Charlotte, North Carolina
- 1237.6.01114 Boehringer Ingelheim Investigational Site
Location: Cincinnati, Ohio
- 1237.6.01102 Boehringer Ingelheim Investigational Site
Location: Columbus, Ohio
- 1237.6.01115 Boehringer Ingelheim Investigational Site
Location: Oklahoma City, Oklahoma
- 1237.6.01101 Boehringer Ingelheim Investigational Site
Location: Philadelphia, Pennsylvania
- 1237.6.01113 Boehringer Ingelheim Investigational Site
Location: East Providence, Rhode Island
- 1237.6.01122 Boehringer Ingelheim Investigational Site
Location: Charleston, South Carolina
- 1237.6.01132 Boehringer Ingelheim Investigational Site
Location: Greenville, South Carolina
- 1237.6.01137 Boehringer Ingelheim Investigational Site
Location: Greenville, South Carolina
- 1237.6.01111 Boehringer Ingelheim Investigational Site
Location: Spartanburg, South Carolina
- 1237.6.01105 Boehringer Ingelheim Investigational Site
Location: Union, South Carolina
- 1237.6.01138 Boehringer Ingelheim Investigational Site
Location: Killeen, Texas
- 1237.6.01124 Boehringer Ingelheim Investigational Site
Location: McKinney, Texas
- 1237.6.01112 Boehringer Ingelheim Investigational Site
Location: Richmond, Virginia
- 1237.6.01133 Boehringer Ingelheim Investigational Site
Location: Richmond, Virginia
- 1237.6.01125 Boehringer Ingelheim Investigational Site
Location: Spokane, Washington
- 1237.6.01103 Boehringer Ingelheim Investigational Site
Location: Tacoma, Washington
|